ACMD review of naloxone provision 2022

Two BDP workers holding naloxone in front of naloxone poster campaign

The Advisory Council on the Misuse of Drugs(ACMD) has published a self-commissioned review of the evidence on the provision and availability of naloxone in the UK. Naloxone is a medicine that can temporarily reverse the effects of opioids and is used as an emergency treatment for people suspected to be experiencing an opioid overdose. The review looks at the provision and availability of naloxone and has made a number of recommendations to optimise the use of naloxone to reduce drug-related harms.

BDP supply the majority of naloxone in the Bristol area and because of this we were asked to contribute to the report. We submitted information on the prevalence and provision of naloxone, how many people were carrying it, how many people are using it and a series of recommendations from our own experiences that would improve naloxone provision in the UK. This information was comprised of statistics from our records, along with input, opinions and case studies from BDP service users, people who have received naloxone training from BDP and our staff.

We welcome the recommendations put forward by the ACMD after gathering this wealth of evidence which include:

2 minute read

Related to this article

ACMD review of naloxone provision 2022

Bristol Drug Project

ACMD review of naloxone provision 2022

The Advisory Council on the Misuse of Drugs(ACMD) has published a self-commissioned review of the evidence on the provision ...

The Drop Summer Festival Schedule

Bristol Drug Project

The Drop Summer Festival Schedule

This festival season is set to be our busiest yet and we can’t wait! After the dreaded c-word cancelled all events in 2020...

Drug checking is coming to Bristol

Bristol Drug Project

Drug checking is coming to Bristol

We are delighted to announce that the first regular city-centre drug checking service licensed by the Home Office is coming ...